Glicopirrónio Axidrox (Glycopyrronium Bromide)

Glicopirrónio Axidrox is prescribed for the topical treatment of excessive sweating in specific areas.

• Primary axillary hyperhidrosis (excessive under‑arm sweating).
• Secondary axillary hyperhidrosis when other causes have been excluded.
• Adjunctive therapy for patients who have not responded to topical antiperspirants.
• Use in adults under medical supervision for localized hyperhidrosis.
• May be considered when non‑pharmacologic measures (e.g., lifestyle changes) are insufficient.

The safety profile of Glicopirrónio Axidrox includes both frequently observed and less common reactions.

Common

• Mild skin irritation at the application site.
• Dryness or flaking of the treated skin.
• Redness (erythema) or mild itching.
• Transient burning or stinging sensation.
• Light‑headedness or mild headache.
• Temporary increase in skin temperature.

Serious

• Allergic reactions such as urticaria or angioedema.
• Severe skin necrosis or ulceration.
• Blurred vision or difficulty focusing.
• Urinary retention or difficulty urinating.
• Tachycardia or irregular heart rhythm.
• Significant systemic anticholinergic effects (e.g., confusion, dry mouth).

Before initiating Glicopirrónio Axidrox, clinicians should evaluate several precautionary factors.

• Confirm the diagnosis of primary axillary hyperhidrosis.
• Assess for hypersensitivity to glycopyrronium bromide or any formulation excipients.
• Use with caution in patients with glaucoma, urinary retention, or gastrointestinal obstruction.
• Avoid application on broken, inflamed, or infected skin.
• Advise patients to wash their hands after application to prevent accidental contact with eyes or mucous membranes.
• Monitor for systemic anticholinergic effects, especially in elderly patients.

Glicopirrónio Axidrox may interact with other medications that possess anticholinergic activity or affect sweat gland function.

Avoid

• Concurrent use of other topical anticholinergic agents on the same area.
• Systemic anticholinergic drugs (e.g., antihistamines, tricyclic antidepressants) that could increase overall anticholinergic burden.

Use with caution

• Beta‑blockers or other agents that influence heart rate.
• Medications that cause dry mouth or constipation, potentially augmenting side effects.
• Ophthalmic anticholinergics, as combined use may increase risk of blurred vision.